Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming - COVID-19 Clinical Trial
Breaking News | COVID-19

Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming

Paused studies of leading Covid-19 vaccine candidates from AstraZeneca PLC and Johnson & Johnson are resuming, the companies said Friday.The restarts mean testing of two of the most advanced Covid-19 vaccines in development can get back on track after their testing had been sidetracked. The testing is crucial for regulators to evaluate whether the vaccines safely protect against the virus and should be given widely.

The U.S. Food and Drug Administration had wrapped up an examination of two cases of a possible neurological side effect that emerged in two people in studies testing AstraZeneca’s shot, and said a late-stage trial in the U.S. can resume, according to the company.The AstraZeneca decision, which was first reported by The Wall Street Journal, came after the FDA didn’t find the vaccine was responsible for the two cases, though the agency couldn’t rule out a link either, a person familiar with the matter said.The agency plans to require researchers to inform study subjects of the cases and monitor them for any related neurological events, such as numbness, the person said.

US Reports Highest Number of Cases Since Pandemic Began

The United States had more than 481,372 new cases of COVID-19 last week, setting a record for the most new cases reported in a week since the pandemic began. Nearly half the country set records for new COVID-19 cases in a week while five states had a record number of deaths in a week: Montana, North Carolina, South Dakota, Wisconsin and Wyoming. The U.S. reports a new COVID-19 case every 1.26 seconds, according to a USA TODAY analysis of Johns Hopkins University data

Share this:

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.